|
The ABL Advisor Deal Tables
SELECTED TRANSACTION DETAILS
BizCap Secures $45MM Credit Facility for Nivagen Pharamaceuticals
Tuesday, September 27, 2022
|
Lenders/Participants
|
BizCap [Lender]
|
|
Structure
|
$20MM Revolver' $25MM Term Loan
|
|
Amount
|
$45.000
Million
|
|
Borrower(s)
|
Nivagen Pharmaceuticals
|
|
Description
|
The credit facility is comprised of a $20 million revolving line of credit to facilitate working capital needs and a $25 million term loan, the proceeds of which will be used to build out a 63,500 square foot state-of-the-art sterile manufacturing R&D facility which will enable Nivagen to onshore its production capabilities.
|
|
Industry
|
Pharmaceuticals
|
| Related Tags |
BizCap
|
ABL Advisor
Deal Tables
2024
|
|
|
|